40
Participants
Start Date
December 12, 2024
Primary Completion Date
September 30, 2028
Study Completion Date
September 30, 2029
Sapanisertib
Oral
Serabelisib
Oral
Paclitaxel
Infusion
RECRUITING
Women's Cancer Care Associates, LLC, Albany
RECRUITING
West Penn Hospital, Pittsburgh
RECRUITING
Alliance Cancer Specialists, PC, Doylestown
RECRUITING
Maryland Oncology Hematology, P.A., Brandywine
RECRUITING
Virginia Cancer Specialists, P.C., Fairfax
RECRUITING
Mount Sinai Comprehensive Cancer Center, Miami Beach
RECRUITING
Florida Cancer Specialists, East, West Palm Beach
RECRUITING
Florida Cancer Specialists, North, St. Petersburg
RECRUITING
University of Cincinnati Medical Center, Cincinnati
RECRUITING
Minnesota Oncology Hematology, P.A., Maple Grove
RECRUITING
Avera Cancer Institute, Sioux Falls
RECRUITING
Texas Oncology - Gulf Coast, The Woodlands
RECRUITING
UC San Diego Moores Cancer Center, La Jolla
RECRUITING
University of California, San Francisco (UCSF), San Francisco
RECRUITING
Northwest Cancer Specialists, P.C., Portland
RECRUITING
Oncology Associates of Oregon, P.C., Eugene
Lead Sponsor
Faeth Therapeutics
INDUSTRY
GOG Foundation
NETWORK